Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 123 articles:
HTML format
Text format



Single Articles


    January 2017
  1. GOTTING M, Schwarzer M, Gerber A, Klingelhofer D, et al
    Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.
    PLoS One. 2017;12:e0169238.
    PubMed     Text format     Abstract available


  2. HIMORI K, Abe M, Tatebayashi D, Lee J, et al
    Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.
    PLoS One. 2017;12:e0169146.
    PubMed     Text format     Abstract available


  3. DUMAS DE LA ROQUE E, Smeralda G, Quignard JF, Freund-Michel V, et al
    Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.
    PLoS One. 2017;12:e0173044.
    PubMed     Text format     Abstract available


  4. WANG X, Shults NV, Suzuki YJ
    Oxidative profiling of the failing right heart in rats with pulmonary hypertension.
    PLoS One. 2017;12:e0176887.
    PubMed     Text format     Abstract available


  5. TANAKA H, Kataoka M, Isobe S, Yamamoto T, et al
    Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension.
    PLoS One. 2017;12:e0180615.
    PubMed     Text format     Abstract available


  6. PEREZ M, Lee KJ, Cardona HJ, Taylor JM, et al
    Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
    PLoS One. 2017;12:e0180957.
    PubMed     Text format     Abstract available


  7. SZEMA AM, Forsyth E, Ying B, Hamidi SA, et al
    NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
    PLoS One. 2017;12:e0170606.
    PubMed     Text format     Abstract available


  8. MIDDLETON RC, Fournier M, Xu X, Marban E, et al
    Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension.
    PLoS One. 2017;12:e0183557.
    PubMed     Text format     Abstract available


  9. LOOMIS Z, Eigenberger P, Redinius K, Lisk C, et al
    Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation.
    PLoS One. 2017;12:e0171219.
    PubMed     Text format     Abstract available


  10. POOR HD, Kawut SM, Liu CY, Smith BM, et al
    Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study.
    PLoS One. 2017;12:e0176812.
    PubMed     Text format     Abstract available


  11. SOKUNBI OJ, Ekure EN, Temiye EO, Anyanwu R, et al
    Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.
    PLoS One. 2017;12:e0184287.
    PubMed     Text format     Abstract available


  12. LAN CC, Peng CK, Tang SE, Huang KL, et al
    Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury.
    PLoS One. 2017;12:e0179822.
    PubMed     Text format     Abstract available


  13. FUCHS H, Rossmann N, Schmid MB, Hoenig M, et al
    Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience.
    PLoS One. 2017;12:e0179974.
    PubMed     Text format     Abstract available


  14. REVUZ S, Decullier E, Ginon I, Lamblin N, et al
    Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability.
    PLoS One. 2017;12:e0184227.
    PubMed     Text format     Abstract available


  15. JERNIGAN NL, Naik JS, Weise-Cross L, Detweiler ND, et al
    Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.
    PLoS One. 2017;12:e0180455.
    PubMed     Text format     Abstract available


  16. ZUNGU-EDMONDSON M, Shults NV, Melnyk O, Suzuki YJ, et al
    Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    PLoS One. 2017;12:e0182551.
    PubMed     Text format     Abstract available


  17. LE GOUELLEC N, Duhamel A, Perez T, Hachulla AL, et al
    Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
    PLoS One. 2017;12:e0181692.
    PubMed     Text format     Abstract available


  18. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    PubMed     Text format     Abstract available


  19. VENTETUOLO CE, Hess E, Austin ED, Baron AE, et al
    Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.
    PLoS One. 2017;12:e0187734.
    PubMed     Text format     Abstract available


  20. SATO T, Tsujino I, Ohira H, Oyama-Manabe N, et al
    Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension.
    PLoS One. 2017;12:e0187806.
    PubMed     Text format     Abstract available


  21. GHIO S, Crimi G, Pica S, Temporelli PL, et al
    Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
    PLoS One. 2017;12:e0188383.
    PubMed     Text format     Abstract available


  22. LOPEZ-MESEGUER M, Quezada CA, Ramon MA, Lazaro M, et al
    Lung and heart-lung transplantation in pulmonary arterial hypertension.
    PLoS One. 2017;12:e0187811.
    PubMed     Text format     Abstract available


    January 2016
  23. XI Q, Liu Z, Zhao Z, Luo Q, et al
    High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0147396.
    PubMed     Text format     Abstract available


  24. GUBRIJ IB, Pangle AK, Pang L, Johnson LG, et al
    Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    PLoS One. 2016;11:e0147827.
    PubMed     Text format     Abstract available


  25. LI Q, Mao M, Qiu Y, Liu G, et al
    Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension.
    PLoS One. 2016;11:e0149164.
    PubMed     Text format     Abstract available


  26. RAFIKOVA O, Meadows ML, Kinchen JM, Mohney RP, et al
    Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.
    PLoS One. 2016;11:e0150480.
    PubMed     Text format     Abstract available


  27. RICHTER MJ, Milger K, Haase S, Sommer N, et al
    The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0152580.
    PubMed     Text format     Abstract available


  28. YIN X, Wang L, Qin G, Luo H, et al
    Rats with Chronic, Stable Pulmonary Hypertension Tolerate Low Dose Sevoflurane Inhalation as Well as Normal Rats Do.
    PLoS One. 2016;11:e0154154.
    PubMed     Text format     Abstract available


  29. PAGANO JJ, Chow K, Khan A, Michelakis E, et al
    Reduced Right Ventricular Native Myocardial T1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls.
    PLoS One. 2016;11:e0157565.
    PubMed     Text format     Abstract available


  30. WANG Q, Guo YZ, Zhang YT, Xue JJ, et al
    The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0157171.
    PubMed     Text format     Abstract available


  31. YANG L, Yu D, Mo R, Zhang J, et al
    The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy.
    PLoS One. 2016;11:e0147597.
    PubMed     Text format     Abstract available


  32. HUANG WC, Ke MW, Cheng CC, Chiou SH, et al
    Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0142476.
    PubMed     Text format     Abstract available


  33. NIELSEN EA, Sun M, Honjo O, Hjortdal VE, et al
    Dual Endothelin Receptor Blockade Abrogates Right Ventricular Remodeling and Biventricular Fibrosis in Isolated Elevated Right Ventricular Afterload.
    PLoS One. 2016;11:e0146767.
    PubMed     Text format     Abstract available


  34. WEST JD, Carrier EJ, Bloodworth NC, Schroer AK, et al
    Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0148657.
    PubMed     Text format     Abstract available


  35. PARIKH RV, Ma Y, Scherzer R, Heringer AS, et al
    Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection.
    PLoS One. 2016;11:e0146355.
    PubMed     Text format     Abstract available


  36. GALAMBOS C, Minic AD, Bush D, Nguyen D, et al
    Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension.
    PLoS One. 2016;11:e0159005.
    PubMed     Text format     Abstract available


  37. AL-ALLAWI N, Mohammad AM, Jamal S
    Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.
    PLoS One. 2016;11:e0162036.
    PubMed     Text format     Abstract available


  38. JUJO T, Tanabe N, Sakao S, Ishibashi-Ueda H, et al
    Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0161827.
    PubMed     Text format     Abstract available


  39. RENGIER F, Worz S, Melzig C, Ley S, et al
    Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension.
    PLoS One. 2016;11:e0162516.
    PubMed     Text format     Abstract available


  40. COLLACO JM, Dadlani GH, Nies MK, Leshko J, et al
    Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension.
    PLoS One. 2016;11:e0163904.
    PubMed     Text format     Abstract available


  41. RICHTER MJ, Tiede SL, Sommer N, Schmidt T, et al
    Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
    PLoS One. 2016;11:e0165982.
    PubMed     Text format     Abstract available


  42. SUGIMOTO K, Yoshihisa A, Nakazato K, Jin Y, et al
    Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0165603.
    PubMed     Text format     Abstract available


  43. JANKOWICH M, Elston B, Evans SK, Wu WC, et al
    Relationship of Iron Deficiency and Serum Ferritin Levels with Pulmonary Hypertension: The Jackson Heart Study.
    PLoS One. 2016;11:e0167987.
    PubMed     Text format     Abstract available


  44. KOVACS G, Avian A, Foris V, Tscherner M, et al
    Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.
    PLoS One. 2016;11:e0168706.
    PubMed     Text format     Abstract available


  45. WANG L, Qu M, Chen Y, Zhou Y, et al
    Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0168101.
    PubMed     Text format     Abstract available


  46. PARK DW, Sebastiani A, Yap CH, Simon MA, et al
    Quantification of Coupled Stiffness and Fiber Orientation Remodeling in Hypertensive Rat Right-Ventricular Myocardium Using 3D Ultrasound Speckle Tracking with Biaxial Testing.
    PLoS One. 2016;11:e0165320.
    PubMed     Text format     Abstract available


  47. FARHA S, Hu B, Comhair S, Zein J, et al
    Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0156042.
    PubMed     Text format     Abstract available


  48. SAHOO S, Meijles DN, Al Ghouleh I, Tandon M, et al
    MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0153780.
    PubMed     Text format     Abstract available


  49. WU Y, Adi D, Long M, Wang J, et al
    4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats.
    PLoS One. 2016;11:e0157538.
    PubMed     Text format     Abstract available


  50. ROSE JA, Wanner N, Cheong HI, Queisser K, et al
    Flow Cytometric Quantification of Peripheral Blood Cell beta-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0156940.
    PubMed     Text format     Abstract available


  51. BUJAK R, Mateo J, Blanco I, Izquierdo-Garcia JL, et al
    New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans.
    PLoS One. 2016;11:e0160505.
    PubMed     Text format     Abstract available


    January 2015
  52. LAN B, Hayama E, Kawaguchi N, Furutani Y, et al
    Therapeutic efficacy of valproic Acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
    PLoS One. 2015;10:e0117211.
    PubMed     Text format     Abstract available



  53. Correction: Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy.
    PLoS One. 2015;10:e0118428.
    PubMed     Text format     Abstract available


  54. AL-HUSSEINI A, Wijesinghe DS, Farkas L, Kraskauskas D, et al
    Increased eicosanoid levels in the sugen/chronic hypoxia model of severe pulmonary hypertension.
    PLoS One. 2015;10:e0120157.
    PubMed     Text format     Abstract available


  55. STEINER J, Wu WC, Jankowich M, Maron BA, et al
    Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities.
    PLoS One. 2015;10:e0119277.
    PubMed     Text format     Abstract available



  56. Correction: Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity.
    PLoS One. 2015;10:e0119787.
    PubMed     Text format     Abstract available


  57. SUN DD, Hou CJ, Yuan LJ, Duan YY, et al
    Hemodynamic changes of the middle hepatic vein in patients with pulmonary hypertension using echocardiography.
    PLoS One. 2015;10:e0121408.
    PubMed     Text format     Abstract available


  58. DONG C, Zhou M, Liu D, Long X, et al
    Diagnostic Accuracy of Computed Tomography for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0126985.
    PubMed     Text format     Abstract available


  59. KOHYAMA T, Moriyama K, Kanai R, Kotani M, et al
    Accuracy of pulse oximeters in detecting hypoxemia in patients with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2015;10:e0126979.
    PubMed     Text format     Abstract available


  60. SEIMETZ M, Parajuli N, Pichl A, Bednorz M, et al
    Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
    PLoS One. 2015;10:e0129327.
    PubMed     Text format     Abstract available


  61. PARK SH, Chen WC, Durmus N, Bleck B, et al
    The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.
    PLoS One. 2015;10:e0129910.
    PubMed     Text format     Abstract available


  62. LI Y, Wang Y, Zhai Z, Guo X, et al
    Real-Time Three-Dimensional Echocardiography to Assess Right Ventricle Function in Patients with Pulmonary Hypertension.
    PLoS One. 2015;10:e0129557.
    PubMed     Text format     Abstract available


  63. MOREIRA EM, Gall H, Leening MJ, Lahousse L, et al
    Prevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study.
    PLoS One. 2015;10:e0130072.
    PubMed     Text format     Abstract available


  64. JACQUIN S, Rincheval V, Mignotte B, Richard S, et al
    Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.
    PLoS One. 2015;10:e0131940.
    PubMed     Text format     Abstract available


  65. WANG AP, Li XH, Yang YM, Li WQ, et al
    A Critical Role of the mTOR/eIF2alpha Pathway in Hypoxia-Induced Pulmonary Hypertension.
    PLoS One. 2015;10:e0130806.
    PubMed     Text format     Abstract available


  66. LADOR F, Herve P, Bringard A, Gunther S, et al
    Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension.
    PLoS One. 2015;10:e0134221.
    PubMed     Text format     Abstract available


  67. JUJO T, Sakao S, Ishibashi-Ueda H, Ishida K, et al
    Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.
    PLoS One. 2015;10:e0133167.
    PubMed     Text format     Abstract available


  68. LOBO CL, do Nascimento EM, Abelha R, Queiroz AM, et al
    Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia.
    PLoS One. 2015;10:e0137539.
    PubMed     Text format     Abstract available


  69. JUJO T, Sakao S, Ishibashi-Ueda H, Ishida K, et al
    Correction: Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.
    PLoS One. 2015;10:e0138040.
    PubMed     Text format     Abstract available


  70. LAI YJ, Chang GJ, Yeh YH, Pang JH, et al
    Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase.
    PLoS One. 2015;10:e0137426.
    PubMed     Text format     Abstract available


  71. KOHYAMA T, Moriyama K, Kanai R, Kotani M, et al
    Correction: Accuracy of Pulse Oximeters in Detecting Hypoxemia in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2015;10:e0141944.
    PubMed     Text format     Abstract available


  72. HOEPER MM, Behr J, Held M, Grunig E, et al
    Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
    PLoS One. 2015;10:e0141911.
    PubMed     Text format     Abstract available


  73. MCCULLAGH BN, Costello CM, Li L, O'Connell C, et al
    Elevated Plasma CXCL12alpha Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension.
    PLoS One. 2015;10:e0123709.
    PubMed     Text format     Abstract available


  74. OTSUKI S, Sawada H, Yodoya N, Shinohara T, et al
    Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats.
    PLoS One. 2015;10:e0118655.
    PubMed     Text format     Abstract available


  75. AGUERO J, Ishikawa K, Fish KM, Hammoudi N, et al
    Combination proximal pulmonary artery coiling and distal embolization induces chronic elevations in pulmonary artery pressure in Swine.
    PLoS One. 2015;10:e0124526.
    PubMed     Text format     Abstract available


  76. PROVENCHER S, Paruchuru P, Spezzi A, Waterhouse B, et al
    Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension.
    PLoS One. 2015;10:e0120657.
    PubMed     Text format     Abstract available


  77. SWIFT AJ, Capener D, Hammerton C, Thomas SM, et al
    Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterised by magnetic resonance imaging: pair-matched case controlled study.
    PLoS One. 2015;10:e0127415.
    PubMed     Text format     Abstract available


  78. KIMURA M, Tamura Y, Takei M, Yamamoto T, et al
    Rapid initiation of intravenous epoprostenol infusion is the favored option in patients with advanced pulmonary arterial hypertension.
    PLoS One. 2015;10:e0121894.
    PubMed     Text format     Abstract available


  79. WILSON JL, Yu J, Taylor L, Polgar P, et al
    Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.
    PLoS One. 2015;10:e0123662.
    PubMed     Text format     Abstract available


  80. VIALES RR, Eichstaedt CA, Ehlken N, Fischer C, et al
    Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?
    PLoS One. 2015;10:e0133042.
    PubMed     Text format     Abstract available


  81. ZHAO YD, Chu L, Lin K, Granton E, et al
    A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung.
    PLoS One. 2015;10:e0134958.
    PubMed     Text format     Abstract available


  82. YAMAMURA A, Ohara N, Tsukamoto K
    Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension.
    PLoS One. 2015;10:e0138384.
    PubMed     Text format     Abstract available


  83. HAN QJ, Witschey WR, Fang-Yen CM, Arkles JS, et al
    Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI.
    PLoS One. 2015;10:e0138365.
    PubMed     Text format     Abstract available


  84. ELGENDI M, Kumar S, Guo L, Rutledge J, et al
    Detection of Heart Sounds in Children with and without Pulmonary Arterial Hypertension-Daubechies Wavelets Approach.
    PLoS One. 2015;10:e0143146.
    PubMed     Text format     Abstract available


    January 2014
  85. WANG Y, Loghmanpour N, Vandenberghe S, Ferreira A, et al
    Simulation of dilated heart failure with continuous flow circulatory support.
    PLoS One. 2014;9:e85234.
    PubMed     Text format     Abstract available


  86. BAUER EM, Zheng H, Lotze MT, Bauer PM, et al
    Recombinant human interferon alpha 2b prevents and reverses experimental pulmonary hypertension.
    PLoS One. 2014;9:e96720.
    PubMed     Text format     Abstract available


  87. WANDALL-FROSTHOLM C, Skaarup LM, Sadda V, Nielsen G, et al
    Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in KCa2.3 and KCa3.1 Channels.
    PLoS One. 2014;9:e97687.
    PubMed     Text format     Abstract available


  88. GORE B, Izikki M, Mercier O, Dewachter L, et al
    Key Role of the Endothelial TGF-beta/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension.
    PLoS One. 2014;9:e100310.
    PubMed     Text format     Abstract available


  89. GUO L, Yang Y, Liu J, Wang L, et al
    Differentially Expressed Plasma MicroRNAs and the Potential Regulatory Function of Let-7b in Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2014;9:e101055.
    PubMed     Text format     Abstract available


  90. KISS T, Kovacs K, Komocsi A, Tornyos A, et al
    Novel Mechanisms of Sildenafil in Pulmonary Hypertension Involving Cytokines/Chemokines, MAP Kinases and Akt.
    PLoS One. 2014;9:e104890.
    PubMed     Text format     Abstract available


  91. MOSER B, Megerle A, Bekos C, Janik S, et al
    Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH.
    PLoS One. 2014;9:e106440.
    PubMed     Text format     Abstract available


  92. DIKALOVA A, Fagiana A, Aschner JL, Aschner M, et al
    Sodium-coupled neutral amino acid transporter 1 (SNAT1) modulates L-citrulline transport and nitric oxide (NO) signaling in piglet pulmonary arterial endothelial cells.
    PLoS One. 2014;9:e85730.
    PubMed     Text format     Abstract available


  93. VALOIS FM, Nery LE, Ramos RP, Ferreira EV, et al
    Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment.
    PLoS One. 2014;9:e87699.
    PubMed     Text format     Abstract available


  94. COLMAN R, Whittingham H, Tomlinson G, Granton J, et al
    Utility of the physical examination in detecting pulmonary hypertension. A mixed methods study.
    PLoS One. 2014;9:e108499.
    PubMed     Text format     Abstract available


  95. BITAR A, Selej M, Bolad I, Lahm T, et al
    Poor agreement between pulmonary capillary wedge pressure and left ventricular end-diastolic pressure in a veteran population.
    PLoS One. 2014;9:e87304.
    PubMed     Text format     Abstract available


  96. KASAI H, Sugiura T, Tanabe N, Sakurai Y, et al
    Electrocardiogram-gated 320-slice multidetector computed tomography for the measurement of pulmonary arterial distensibility in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2014;9:e111563.
    PubMed     Text format     Abstract available


  97. WEI C, Kim IK, Li L, Wu L, et al
    Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy.
    PLoS One. 2014;9:e110598.
    PubMed     Text format     Abstract available


  98. NAITO A, Tanabe N, Jujo T, Shigeta A, et al
    Pentraxin3 in Chronic Thromboembolic Pulmonary Hypertension: A New Biomarker for Screening from Remitted Pulmonary Thromboembolism.
    PLoS One. 2014;9:e113086.
    PubMed     Text format     Abstract available


  99. MORALES-CANO D, Menendez C, Moreno E, Moral-Sanz J, et al
    The flavonoid quercetin reverses pulmonary hypertension in rats.
    PLoS One. 2014;9:e114492.
    PubMed     Text format     Abstract available


  100. SHARMA M, Singh SB, Sarkar S
    Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema.
    PLoS One. 2014;9:e85902.
    PubMed     Text format     Abstract available


  101. LI Z, Liang X, Liu S, Ye Z, et al
    Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity.
    PLoS One. 2014;9:e114392.
    PubMed     Text format     Abstract available


  102. SEN P, Dharmadhikari AV, Majewski T, Mohammad MA, et al
    Comparative analyses of lung transcriptomes in patients with alveolar capillary dysplasia with misalignment of pulmonary veins and in foxf1 heterozygous knockout mice.
    PLoS One. 2014;9:e94390.
    PubMed     Text format     Abstract available


  103. POELS EM, Bitsch N, Slenter JM, Kooi ME, et al
    Supplementing exposure to hypoxia with a copper depleted diet does not exacerbate right ventricular remodeling in mice.
    PLoS One. 2014;9:e92983.
    PubMed     Text format     Abstract available


  104. TALATI M, West J, Zaynagetdinov R, Hong CC, et al
    BMP pathway regulation of and by macrophages.
    PLoS One. 2014;9:e94119.
    PubMed     Text format     Abstract available


  105. MANSOOR JK, Schelegle ES, Davis CE, Walby WF, et al
    Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension.
    PLoS One. 2014;9:e95331.
    PubMed     Text format     Abstract available


  106. ZHAO Y, Peng J, Lu C, Hsin M, et al
    Metabolomic heterogeneity of pulmonary arterial hypertension.
    PLoS One. 2014;9:e88727.
    PubMed     Text format     Abstract available


  107. TAN X, Yang W, Guo J, Zhang Y, et al
    Usefulness of Decrease in Oxygen Uptake Efficiency to Identify Gas Exchange Abnormality in Patients with Idiopathic Pulmonary Arterial Hypertension.
    PLoS One. 2014;9:e98889.
    PubMed     Text format     Abstract available


  108. TAN Y, Tseng PO, Wang D, Zhang H, et al
    Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-kappaB pathway.
    PLoS One. 2014;9:e102195.
    PubMed     Text format     Abstract available


  109. MAINGUY V, Malenfant S, Neyron AS, Saey D, et al
    Alternatives to the six-minute walk test in pulmonary arterial hypertension.
    PLoS One. 2014;9:e103626.
    PubMed     Text format     Abstract available


  110. HINDERHOFER K, Fischer C, Pfarr N, Szamalek-Hoegel J, et al
    Identification of a New Intronic BMPR2-Mutation and Early Diagnosis of Heritable Pulmonary Arterial Hypertension in a Large Family with Mean Clinical Follow-Up of 12 Years.
    PLoS One. 2014;9:e91374.
    PubMed     Text format     Abstract available


  111. NAGAI H, Kuwahira I, Schwenke DO, Tsuchimochi H, et al
    beta2-Adrenergic Receptor-Dependent Attenuation of Hypoxic Pulmonary Vasoconstriction Prevents Progression of Pulmonary Arterial Hypertension in Intermittent Hypoxic Rats.
    PLoS One. 2014;9:e110693.
    PubMed     Text format     Abstract available


  112. DAS M, Boerma M, Goree JR, Lavoie EG, et al
    Pathological Changes in Pulmonary Circulation in Carbon Tetrachloride (ccl4)-Induced Cirrhotic Mice.
    PLoS One. 2014;9:e96043.
    PubMed     Text format     Abstract available


  113. POUSADA G, Baloira A, Vilarino C, Cifrian JM, et al
    Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension.
    PLoS One. 2014;9:e100261.
    PubMed     Text format     Abstract available


  114. SADAMURA-TAKENAKA Y, Ito T, Noma S, Oyama Y, et al
    HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats.
    PLoS One. 2014;9:e102482.
    PubMed     Text format     Abstract available


  115. SUN LY, Zhao H, Kang Y, Shen XD, et al
    Two-dimensional echocardiography in the assessment of long-term prognosis in patients with pulmonary arterial hypertension.
    PLoS One. 2014;9:e114443.
    PubMed     Text format     Abstract available


  116. BREDA AP, Pereira de Albuquerque AL, Jardim C, Morinaga LK, et al
    Skeletal muscle abnormalities in pulmonary arterial hypertension.
    PLoS One. 2014;9:e114101.
    PubMed     Text format     Abstract available


    January 2013
  117. GROEPENHOFF H , Vonk-Noordegraaf A, van de Veerdonk MC, Boonstra A, et al
    Prognostic relevance of changes in exercise test variables in pulmonary arterial hypertension.
    PLoS One. 2013;8:e72013.
    PubMed     Text format     Abstract available


  118. FRUMP AL , Lowery JW, Hamid R, Austin ED, et al
    Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.
    PLoS One. 2013;8:e80319.
    PubMed     Text format     Abstract available


  119. JIANG DM , Han J, Zhu JH, Fu GS, et al
    Paracrine Effects of Bone Marrow-Derived Endothelial Progenitor Cells: Cyclooxygenase-2/Prostacyclin Pathway in Pulmonary Arterial Hypertension.
    PLoS One. 2013;8:e79215.
    PubMed     Text format     Abstract available


  120. PRICE LC , Caramori G, Perros F, Meng C, et al
    Nuclear Factor kappa-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension.
    PLoS One. 2013;8:e75415.
    PubMed     Text format     Abstract available


  121. WAGNER BD, Takatsuki S, Accurso FJ, Ivy DD, et al
    Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension.
    PLoS One. 2013;8:e80235.
    PubMed     Text format     Abstract available


  122. KOPEC G, Moertl D, Steiner S, Stepien E, et al
    Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension.
    PLoS One. 2013;8:e82628.
    PubMed     Text format     Abstract available


  123. TIO D , Leter E, Boerrigter B, Boonstra A, et al
    Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension.
    PLoS One. 2013;8:e78132.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: